News
Hosted on MSN9mon
Researchers suggest rethinking 'cancer' label for early-stage prostate changes - MSNIn 2022, there were nearly 1.5 million cases of prostate cancer, but only 400,000 deaths. Low-grade prostate cancer, commonly known as GG1 among physicians, virtually never metastasizes or causes ...
With the Optilume BPH catheter system, urologists inflate a balloon to split the lobes of the prostate. A second balloon can further separate the lobes and deliver a drug, paclitaxel ― best ...
Hosted on MSN11mon
Bayers to seek label expansion for prostate cancer drug after late-stage trial win - MSNBayer (OTCPK:BAYZF) on Wednesday announced plans to seek an expanded label for its prostate cancer therapy Nubeqa (darolutamide) after the oral androgen receptor inhibitor (ARi) as part of ...
kidney-stone-formersand vasular-calcium Prostatic arterial embolization significantly reduced volumes of median lobes, central zones, peripheral zones, and whole prostate glands. Prostatic ...
The technical recommendations of an international group of experts on photoselective vaporization of the prostate (PVP; GreenLight PV) for benign prostatic hyperplasia are described. Their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results